These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 24223100)
1. Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells. Kornblau SM; Qutub A; Yao H; York H; Qiu YH; Graber D; Ravandi F; Cortes J; Andreeff M; Zhang N; Coombes KR PLoS One; 2013; 8(10):e78453. PubMed ID: 24223100 [TBL] [Abstract][Full Text] [Related]
2. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia. Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948 [TBL] [Abstract][Full Text] [Related]
3. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells. Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383 [TBL] [Abstract][Full Text] [Related]
4. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A; Gillis D; Lewis I J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508 [TBL] [Abstract][Full Text] [Related]
11. The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. van Rhenen A; van Dongen GA; Kelder A; Rombouts EJ; Feller N; Moshaver B; Stigter-van Walsum M; Zweegman S; Ossenkoppele GJ; Jan Schuurhuis G Blood; 2007 Oct; 110(7):2659-66. PubMed ID: 17609428 [TBL] [Abstract][Full Text] [Related]
12. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection. Al-Mawali A; Pinto AD; Al-Zadjali S Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396 [TBL] [Abstract][Full Text] [Related]
13. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2. Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151 [TBL] [Abstract][Full Text] [Related]
14. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595 [TBL] [Abstract][Full Text] [Related]
15. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Ito S; Barrett AJ; Dutra A; Pak E; Miner S; Keyvanfar K; Hensel NF; Rezvani K; Muranski P; Liu P; Larochelle A; Melenhorst JJ Stem Cell Res; 2015 Jan; 14(1):95-104. PubMed ID: 25535865 [TBL] [Abstract][Full Text] [Related]
16. Senescence effects of Angelica sinensis polysaccharides on human acute myelogenous leukemia stem and progenitor cells. Liu J; Xu CY; Cai SZ; Zhou Y; Li J; Jiang R; Wang YP Asian Pac J Cancer Prev; 2014 Jan; 14(11):6549-56. PubMed ID: 24377566 [TBL] [Abstract][Full Text] [Related]
17. CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin. Herrmann H; Cerny-Reiterer S; Gleixner KV; Blatt K; Herndlhofer S; Rabitsch W; Jäger E; Mitterbauer-Hohendanner G; Streubel B; Selzer E; Schwarzinger I; Sperr WR; Valent P Haematologica; 2012 Feb; 97(2):219-26. PubMed ID: 21993666 [TBL] [Abstract][Full Text] [Related]
18. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML. Herrmann H; Sadovnik I; Eisenwort G; Rülicke T; Blatt K; Herndlhofer S; Willmann M; Stefanzl G; Baumgartner S; Greiner G; Schulenburg A; Mueller N; Rabitsch W; Bilban M; Hoermann G; Streubel B; Vallera DA; Sperr WR; Valent P Blood Adv; 2020 Oct; 4(20):5118-5132. PubMed ID: 33085758 [TBL] [Abstract][Full Text] [Related]
19. [In Vitro Identification and Characteristics of CD34 Zhang YH; Yang L; Wang YZ; Kong Y; Zhu HH; Qin YZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1289-1294. PubMed ID: 29070097 [TBL] [Abstract][Full Text] [Related]
20. A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Gerber JM; Smith BD; Ngwang B; Zhang H; Vala MS; Morsberger L; Galkin S; Collector MI; Perkins B; Levis MJ; Griffin CA; Sharkis SJ; Borowitz MJ; Karp JE; Jones RJ Blood; 2012 Apr; 119(15):3571-7. PubMed ID: 22262762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]